Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis

<p>Introduction: Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, reduced the risk of heart and kidney outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in FIDELITY, a prespecified pooled analysis of the FIDELIO-DKD and FIGARO-DKD trials. Th...

Description complète

Détails bibliographiques

Auteurs principaux:	Ping Li, Yu An, Hongguang Zheng, Weiping Lu, Zhaohui Mo, Xudong Xu, Yibing Lu, Chaoqing Wu, Jingyuan Xie, Nanwei Tong, Fang Liu, Qinkai Chen, Jingjing Tang, Meike Brinker, Luke Roberts, Dalong Zhu, Zhihong Liu
Format:	Artigo
Langue:	Inglês
Publié:	Karger Publishers 2026-01-01
Collection:	Kidney Diseases
Accès en ligne:	https://karger.com/article/doi/10.1159/000550850
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!